101
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services

, , &
Pages 131-146 | Published online: 08 Jul 2009

References

  • Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute visual function questionnaire (NEI-VFQ). Arch Ophthalmol. 1998;116: 1496–1504.
  • Mangione CM, Gutierrez PR, Lowe G, et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol. 1999;128: 45–53.
  • Mackenzie PJ, Chang TS, Scott IU, et al. Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology. 2002;109:720–729.
  • Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001; 108:1893–1901.
  • Williams RA, Brody BL, Thomas RG, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116:514–520.
  • Rovner B, Casten R. Neuroticism predicts depression and disability in age-related macular degeneration. J Am Geriat Soc. 2001;49: 1097-1mo.
  • Scott IU, Schein OD, Feuer WJ, et al. Emotional distress in patients with retina disease. Am J Ophthalmol. 2001;131:584–589.
  • Davis C, Lovie-Kitchin J, Thompson B. Psychosocial adjustment to age-related macular degeneration. J Vis Impairm Blindness. 1995;89:16–27.
  • Bressler NM, Bressler SB. Photodynamic therapy with verteprofin (Visudyne): impact on ophthalmology and visual science. Invest Ophthalmol Vis ScL 2000;41: 624–628.
  • Age-related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001119: 1417–1436.
  • Jose R. The Low Vision Rehabilitation Service. In: RT J, ed. Understanding Low Vision. New York: American Foundation for the Blind Press, 1983;61–71.
  • McCabe P, Nason F, Turco P, et al. Evaluating the effectiveness of a vision rehabilitation intervention using an objective and subjective measure of functional performance. Ophthalmic Epidemiol. 2000;7: 259–270.
  • Leat SJ, Fryer A, Rumbey NJ. Outcome of low vision aid provision: The effectiveness of a low vision clinic. Optom Vision ScL 1994; 71(3):199–206.
  • Scott IU, Smiddy WE, Schiffman J, et al. Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol. 1999;128:54–62.
  • Gresset J, Durand M, Bolduc M. Responsiveness of a modified version of the Visual Functioning Index (VF-12) for Visual Rehabilitation (VF-12R): preliminary results. In: Stuen C, Arditi A, Horowitz A, et al., eds. Vision Rehabilitation: Assessment, Intervention and Outcomes. New York: Lighthouse International, 1999;152–155.
  • Wolffsohn JS, Cochrane A. Design of the Low Vision Quality-of-Life questionnaire (LCOOL) and measuring the outcomes of low-vision rehabilitation. Am J Ophthalmol. 2000;130:793–802.
  • Stelmack J, Szlyk J, Justin C, et al. Pilot study: use of the NET VFQ-25 to measure outcomes of low vision rehabilitation services in the department of veterans affairs. In: Stuen C, Arditi A, Horowitz A, et al., eds. Vision Rehabilitation: Assessment, Intervention and Outcomes. New York: Swets & Zeitlinger, 1999;774–776.
  • National Advisory Eye Council. Vision Research. A National Plan: 1999–2003. Bethesda: National Eye Institute, National Institutes of Health. US Department of Health and Human Services, 1999; 99–4120.
  • Guyatt G, Feeny D, Patrick D. Issues in quality-of-life measurement in clinical trials. Controlled Clin Trials. 1991;12:8IS–90S.
  • Ellwein LB, Fletcher A, Negrel A, Thulasiraj R. Quality of life assessment in blindness prevention interventions. Int Ophthalmol. 1995; 18:263–268.
  • Deyo R. The quality of life, research, and care. Ann Intern Med. 1991;338:350–351.
  • Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(suppl.)(3): S2 17—S232.
  • Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire (NET VFQ-25). Arch Ophthalmol. 2001;119: 1050–1058.
  • Stelmack JA, Stelmack TR, Massof RW. Measuring low-vision rehabilitation outcomes with the NET VFQ-25. Invest Ophthalmol Vis Sci. 2002;43(9):2859–2868.
  • Owsley C, Stalvey B, Wells J, Sloane ME. Older drivers and cataract: Driving habits and crash risk. J Gerontol: Med Sci. 1999;54A(4): M2o3—M2 I I.
  • Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14.: An index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112: 630–638.
  • Roceaforte WH, Burke WJ, Bayer BL, Wengel SP. Reliability and validity of the short portable mental status questionnaire administered by telephone. J Geriat Psychiat NeuroL 1994;7:33–38.
  • Folstein ME, Folstein SW, McHugh PR. 'Mini-mental state' a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189–198.
  • Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. I982;94(I):91–96.
  • Ferris FLI, Sperduto RD. Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol. 1982;94:97–98.
  • Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32(6): 375–413.
  • DeCarlo D, Scilley K, Wells J, Owsley C. Driving habits and health-related quality of life in patients with age-related macular degeneration. Optom Vision Sci. 2003;80(3):207–213.
  • Fonda SJ, Wallace RB, Herzog AR. Changes in driving patterns and worsening depressive symptoms among older adults. J Gerontol: Social Sci. 2001;56B(6):5343–5351.
  • Marottoli RA, De Leon CFIVI, Glass TA, et al. Driving cessation and increased depressive symptoms: Prospective evidence from the New Haven EPESE. J Am Geriat Soc. 1997;45:202–206.
  • Broman AT, Munoz B, West SK, et al. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest Ophthalmol Vis Sci. 2001;42(3): 606–613.
  • Rubin GS, Munoz B, Bandeen-Roche K, West S, SEE Project team. Monocular versus binocular visual acuity as measures of vision impairment and predictors of visual disability. Invest Ophthalmol Vis Sci. 2000;41(10:3327–3334.
  • Nelson-Quigg JM, Cello K, Johnson CA. Predicting binocular visual field sensitivity from monocular visual field results. Invest Ophthalmol Vis Sci. 2000;41(42212–2221.
  • Owsley C, Stalvey BT, Wells J, et al. Visual risk factors for crash involvement in older drivers with cataract. Arch Ophthalmol. 2001; 119:881–887.
  • Scilley K, Jackson GR, Cideciyan AV, et al. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology. 2002;109(7): 1235–1242.
  • Brown MM, Brown GC, Sharma S, et al. Quality of life associated with unilateral and bilateral good vision. Ophthalmology. 2001;108: 643–648.
  • Pardhan S, Gilchrist J. The importance of measuring binocular contrast sensitiity in unilateral cataract. Eye. 1991;5:31–35.
  • Pardhan S, Elliott DB. Clinical measurements of binocular summation and inhibition in patients with cataract. Clin Vision ScL 1991;6(5):355–359.
  • Faubert J, Overbury O. Binocular vision in older people with adventitious visual impairment: Sometimes one eye is better than two. J Am Geriat Soc. 2000;48: 375–380.
  • Wahl HW, Schilling O, Oswald F, Heyl V. Psychosocial consequences of age-related visual impairment: Comparison with mobility-impaired older adults and long-term outcome. J Gerontol: Psychol Sci. 1999;543(5): P3o4-P316.
  • Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item National Eye Institute visual function questionnaire (NEIVFQ-51). Arch Ophthalmol. 1998;116:227–233.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.